Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 2/20 | 0.46 |
| ▸ | BRD9 | Q9H8M2 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.39 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.39 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Emorfazone SCHEMBL1162007 | 0.78 | ALDH1A1 (0.39) | BRD4BRD9SMN1; SMN2PTGS1L3MBTL1 | |
| Metamizole SCHEMBL5644145 | 0.75 | KDM4E (0.60) | BRD4BRD9KMT2ASMN1; SMN2PTGS1 | |
| SCHEMBL2555460 | 0.73 | BRD4 (0.46) | BRD4BRD9KMT2AMEN1L3MBTL1 | |
| SCHEMBL18394752 | 0.72 | L3MBTL1 (0.52) | KMT2APOLBSMN1; SMN2MEN1L3MBTL1 | |
| SCHEMBL18412809 | 0.67 | KMT2A (0.48) | BRD4BRD9KMT2APOLBSMN1; SMN2 | |
| SCHEMBL26135640 | 0.65 | CYP2C19 (0.44) | BRD4BRD9KMT2APOLBMEN1 | |
| SCHEMBL30493115 | 0.65 | CYP2C19 (0.44) | BRD4BRD9KMT2APOLBMEN1 | |
| SCHEMBL29406578 | 0.64 | SMN1; SMN2 (0.58) | KMT2ATP53POLBSMN1; SMN2MAPK1 | |
| SCHEMBL10414486 | 0.64 | SMN1; SMN2 (0.58) | KMT2ATP53POLBSMN1; SMN2MAPK1 | |
| SCHEMBL16034882 | 0.64 | BRAF (0.48) | SMN1; SMN2MAPK1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5492 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12429483-B2 | System and method for determining onset and disease progression | RESPIRATION SCAN LTD (IL) | 2025-09-30 | — | — | US | claimed |
| WO-2024105529-A1 | CHEMICAL DISBUDDING OF LIVESTOCK | MASSEY UNIVERSITY (NZ) | 2024-05-23 | — | — | WO | claimed |
| US-20240041935-A1 | PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | US | claimed |
| US-20200338144-A1 | AGENT FOR PREVENTING OR TREATING SMALL INTESTINAL INJURY INDUCED BY NON-STEROIDAL ANTI-INFLAMMATORY DRUG AND PROTON PUMP INHIBITOR | BIOFERMIN PHARMACEUTICAL CO., LTD. (JP) | 2020-10-29 | — | — | US | claimed |
| US-20200323883-A1 | METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS | ENTERIN, INC. (US) | 2020-10-15 | — | — | US | claimed |
| EP-3662927-A2 | VACCINE COMPOSITION | NITTO DENKO CORPORATION (JP) | 2020-06-10 | — | — | EP | claimed |
| US-10478444-B2 | Methods and compositions for treating and preventing viral infections | ENTERIN, INC. (US) | 2019-11-19 | — | — | US | claimed |
| US-20180207146-A1 | PHARMACEUTICAL COMPOSITION COMPRISING 5ALPHA-REDUCTASE INHIBITOR | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2018-07-26 | — | — | US | claimed |
| US-20180133230-A1 | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTIONS | ENTERIN LABORATORIES, INC. (US) | 2018-05-17 | — | — | US | claimed |
| EP-3171859-A1 | PHARMACEUTICAL COMPOSITION COMPRISING 5ALPHA-REDUCTASE INHIBITOR | Chong Kun Dang Pharmaceutical Corp. (KR) | 2017-05-31 | — | — | EP | claimed |
| EP-0792371-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-09-03 | — | — | EP | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| EP-0759750-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO, Howard, K. (US) | 1997-03-05 | — | — | EP | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1995031194-A1 | COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES | SHAPIRO HOWARD K (US) | 1995-11-23 | — | — | WO | claimed |
| EP-0059031-B1 | ANALGESIC AND ANTI-INFLAMMATORY COMPOSITION | MORISHITA PHARMACEUTICAL CO. LTD. (JP) | 1985-01-02 | — | — | EP | claimed |
| US-4379148-A | Analgesic and anti-inflammatory composition | MORISHITA PHARMACEUTICAL CO., LTD. (JP) | 1983-04-05 | — | — | US | claimed |
| EP-0059031-A1 | Analgesic and anti-inflammatory composition | MORISHITA PHARMACEUTICAL CO. LTD. (JP) | 1982-09-01 | — | — | EP | claimed |